
Sign up to save your podcasts
Or


Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.
CME information and select publications here.
By Dr. Neil Love4.4
3030 ratings
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.
CME information and select publications here.

43,615 Listeners

317 Listeners

2,060 Listeners

68 Listeners

74 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

120 Listeners

58 Listeners

45 Listeners

26 Listeners

57 Listeners

192 Listeners

44 Listeners

0 Listeners

3 Listeners